PODXL and colonic neoplasm: Interestingly, we found HT29 and HCT15 colon cancer cells that expressed high level of PODXL were more resistant to 5-flurouracil (5-FU) and irinotecan (CPT11), two conventional chemotherapies widely used for colon cancer treatment (Figure 5A,B).